The store will not work correctly when cookies are disabled.
4-butyl-1-(2,6-dichloro-4-ethynylphenyl)-1H-1,2,3-triazole
ID: ALA437753
PubChem CID: 11493073
Max Phase: Preclinical
Molecular Formula: C14H13Cl2N3
Molecular Weight: 294.19
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C#Cc1cc(Cl)c(-n2cc(CCCC)nn2)c(Cl)c1
Standard InChI: InChI=1S/C14H13Cl2N3/c1-3-5-6-11-9-19(18-17-11)14-12(15)7-10(4-2)8-13(14)16/h2,7-9H,3,5-6H2,1H3
Standard InChI Key: HDIDQXQPKFTVHL-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-0.6485 -16.8148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1366 -16.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1398 -15.7360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6467 -15.4787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1299 -16.1463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9549 -16.1453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3630 -15.4305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1872 -15.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6014 -16.1437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1853 -16.8610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3625 -16.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9474 -17.5718 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.9482 -14.7173 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.8026 -17.0479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7141 -17.8682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3802 -18.3550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2916 -19.1752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4264 -16.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2542 -16.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
9 10 1 0
5 1 1 0
10 11 2 0
11 6 1 0
1 2 2 0
11 12 1 0
5 6 1 0
7 13 1 0
2 14 1 0
6 7 2 0
14 15 1 0
2 3 1 0
15 16 1 0
7 8 1 0
16 17 1 0
3 4 2 0
9 18 1 0
8 9 2 0
18 19 3 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.19 | Molecular Weight (Monoisotopic): 293.0487 | AlogP: 3.90 | #Rotatable Bonds: 4 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.22 | CX LogP: 4.76 | CX LogD: 4.76 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.80 | Np Likeness Score: -1.48 |
References
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |